Herbert Y. Meltzer
10Patents
3h-index
8Co-inventors
53Inventor score
Filing activity: Dec 4, 1991 → Nov 15, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10323039B2 | Enantioselective syntheses of heteroyohimbine natural product intermediates | Chemistry; Metallurgy | 11 | Active |
| US10654865B2 | Enantioselective syntheses of heteroyohimbine natural product intermediates | Chemistry; Metallurgy | 7 | Active |
| US5300422A | Screening method for controlling agranulocytosis | Emerging Cross-Sectional Technologies | 7 | Expired |
| US11174514B2 | Methods, kits, and devices utilizing HTR2C polymorphisms for diagnosing, prognosing, and treating psychiatric disorders in a patient | Chemistry; Metallurgy | 2 | Active |
| US10098893B2 | Methods of administering a trace amine-associated receptor 1 (TAAR1) agonist to patients having the minor allele of the single nucleotide polymorphism rs2237457 | Chemistry; Metallurgy | 2 | Active |
| US5221679A | Method of treating therapy resistant schizophrenia with melperone (R-fluoro-Y-methyl-peperidino-butyrophrenone) | Human Necessities | 1 | Expired |
| US11485734B2 | Beta-carbolines as positive allosteric modulators of the human serotonin receptor 2C (5-HT2C) | Human Necessities | 0 | Active |
| US12410474B2 | Methods, kits, and devices for diagnosing, prognosing, and treating psychiatric disorders in a patient | Chemistry; Metallurgy | 0 | Active |
| US8735397B2 | Method for treating schizophrenia and related diseases | Human Necessities | 0 | Active |
| US11666547B2 | Methods for treating cognitive deficits in a subject having schizophrenia, bipolar disorder, or psychiatric depression, and exhibiting cognitive deficits by administering an antagonist of the Na+-K+-2Cl-cation-chloride cotransporter isoform 1 (NKCC1) | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.